My experience includes clinical practice, Pharma industry, and Medical Monitor. I have an internal medicine and medical oncology training. Have also a training in Head & Neck and thoracic tumors at MD Anderson, as well clinical experience in treating a varied group of solid tumors, as well female gynecological neoplasms. Moved to pharma, where I have been responsible in Medical Affairs for solid tumors drugs (breast cancer and antiangiogenic drugs), and onco-hematologic drugs (Multiple Myeloma and Lymphomas). Most recently, I was responsible to provide Lymphoma’s medical strategy leadership for Growth and Emerging Markets, including clinical trials programs and medical training for over 40 countries. At PPD, I provide medical consultation to sponsors and project teams members for clinical trial program development. Experience at PPD includes Phase I-III clinical trial implementation, enrollment and maintenance, including study design, protocol writing, risk assessment and mitigation strategy development, case report form review, eligibility review, unblinding consultation, real-time evaluation of safety information from ongoing studies, processing and reporting of SAEs, data trending and interpretation, and clinical study report review. In addition, active participation in pre-NDA FDA meetings as well FDA Form 1571 Line 16 responsibilities. Maintain comprehensive knowledge of medicine to ensure patient safety, as well as, up to date knowledge of GCP guidelines.